Retrospective analysis of predictors for significant hepatic inflammation in metabolic-associated fatty liver disease with chronic hepatitis B
PeerJ · 2026
DOI: 10.7717/peerj.21186 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2026. Verfasst von Long Hao Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, Fujian Province, China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Non-alcoholic Fatty Liver Disease, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guiding Project of the Science and Technology Department of Fujian Province, Seventh Batch of National Academic Experience Inheritance Projects for Senior Traditional Chinese Medicine Experts.
Abstract (Originalsprache)
Background
The disease burden of metabolic dysfunction–associated fatty liver disease (MAFLD, non-alcoholic) combined with hepatitis B virus (HBV) infection is rising. Hepatic inflammation is a common pathway in liver disease progression, and evaluating its risk factors has clinical significance. In the context of concomitant MAFLD and HBV infection, hepatic inflammation may represent a key pathological pathway driving disease progression, making the assessment of liver inflammation crucial for controlling disease advancement.
Objective
To identify independent risk factors for significant hepatic inflammation (grade ≥ 2) in patients with MAFLD (non-alcoholic) combined with HBV infection.
Methods
This retrospective study included 447 treatment-naïve patients with metabolic dysfunction–associated fatty liver disease (non-alcoholic) and chronic hepatitis B who were diagnosed at Xiamen Hospital of Traditional Chinese Medicine between 2018 and 2024. Patients were stratified by body mass index (BMI) as normal weight (BMI < 25 kg/m 2 ; n = 168), overweight (25 ≤ BMI ≤ 30 kg/m 2 ; n = 234), and obese (BMI > 30 kg/m 2 ; n = 45) to compare inflammatory differences across BMI categories. Liver biopsy was used as the histological reference standard, and multivariable logistic regression was performed to further identify the independent risk factors for significant hepatic inflammation (grade ≥ 2).
Results
Baseline characteristics revealed statistically significant differences among BMI groups in controlled attenuation parameter (CAP), liver stiffness measurement (LSM), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), uric acid (UA), glucose (GLU), hepatitis B surface antigen (HBsAg), hepatitis B e-antigen (HBeAg) positivity rate, and non-invasive indices APRI, GPR, and AAGP (all P < 0.05). A correlation was observed between BMI groups and hepatic inflammation grading ( P < 0.05), persisting even after dichotomizing inflammation grades into G1 versus G2–4 ( P < 0.05). Multivariate logistic regression analysis demonstrated that BMI (OR = 1.12, 95% CI [1.01–1.26]), LSM (OR = 1.34, 95% CI [1.17–1.53]), ALT (OR = 1.01, 95% CI [1.01–1.02]), and HBV DNA (OR = 1.32, 95% CI [1.16–1.51]) were independent risk factors for significant hepatic inflammation (G ≥ 2) (all P < 0.05).
Conclusions
This clinical study was conducted based on histopathological findings and demonstrated that BMI, LSM, and HBV DNA are independent risk factors for the progression of hepatic inflammation in patients with MAFLD and HBV infection, whereas ALT served as an independent non-invasive predictor of this outcome. These findings provide a novel non-invasive approach for clinicians to assess the degree of hepatic inflammation when liver biopsy results are unavailable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatology, Xiamen TCM Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen, Fujian Province, China.
- Department of Hepatology, Xiamen Humanity Hospital, Xiamen, Fujian Province, China.
- Heshan District Health Service Center, Xiamen, Fujian Province, China.
- Department of Liver Disease, 5th Medical Center of Chinese PLA General Hospital, Beijing, China.
Förderung
- National Natural Science Foundation of China
- Guiding Project of the Science and Technology Department of Fujian Province
- Seventh Batch of National Academic Experience Inheritance Projects for Senior Traditional Chinese Medicine Experts
Zitieren
APA
Xu, L. H., He, R. Y., Kang, Y. N., Lin, H. H., Yang, J. E., Chen, H. X., Huang, X. T., Wu, X. L., Pei, B. H., Zhou, C., & Wang, M. (2026). Retrospective analysis of predictors for significant hepatic inflammation in metabolic-associated fatty liver disease with chronic hepatitis B. PeerJ. https://doi.org/10.7717/peerj.21186
Vancouver
Xu LH, He RY, Kang YN, Lin HH, Yang JE, Chen HX, et al. Retrospective analysis of predictors for significant hepatic inflammation in metabolic-associated fatty liver disease with chronic hepatitis B. PeerJ. 2026. doi:10.7717/peerj.21186
BibTeX
@article{Xu2026,
author = {Xu, Long Hao and He, Run Yan and Kang, Yan Neng and Lin, Heng Hong and Yang, Jia En and Chen, Hua Xiao and Huang, Xue Ting and Wu, Xiao Lu and Pei, Bao Hui and Zhou, Chao and Wang, Min},
title = {Retrospective analysis of predictors for significant hepatic inflammation in metabolic-associated fatty liver disease with chronic hepatitis B},
journal = {PeerJ},
year = {2026},
doi = {10.7717/peerj.21186}
}
EUVIMED